Analyst consensus rating
Lexicon Pharmaceuticals Analyst Rating: Buy
Direct answer
Lexicon Pharmaceuticals's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.86.
Forecast evidence checked September 5, 2026.
Get free Lexicon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.24
- Average price target
- $3.86
- High price target
- $6.00
- Low price target
- $2.00
- Low target gap
- -10.7%
- Target upside
- +72.1%
- High target gap
- +167.9%
- Target range width
- 178.6%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals has a verified Buy consensus. The same dataset has an average price target of $3.86.
How far are Lexicon Pharmaceuticals's low and high targets from the recorded price?
The low target implies -10.7%, while the high target implies +167.9%.
How many analysts are included in Lexicon Pharmaceuticals's consensus?
The verified consensus includes 5 analysts.
How is Lexicon Pharmaceuticals's target upside or downside calculated?
The average target of $3.86 is divided by the recorded price of $2.24, then one is subtracted to produce +72.1%. This does not guarantee a future return.
When was Lexicon Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.